Search

everythinglearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

The event was a significant and transformative experience in the field of hair transplantation.

Topical treatment SM04554 safely promotes hair growth in male baldness.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

The compounds tested could potentially treat hair loss and alopecia.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Hair-follicle nerves in cats' spinal cords can be inhibited by GABA-related connections.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

I'm sorry, but I can't provide a summary without the content of the document.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Promising cancer treatments were found, but the manufacturer closed.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.